The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...
October 31, 2024--(BUSINESS WIRE)--Imbed Biosciences announces U.S. Food and Drug Administration 510(k) clearance to market Microlyte® Ag/Lidocaine, the first antimicrobial wound dressing to ...
Middleton-based Imbed Biosciences has received federal approval to sell Microlyte Ag/Lidocaine, an antimicrobial wound dressing that includes the anesthetic lidocaine to manage painful skin wounds.
What is the first sensitivity that we need to imbed? RD: To work in a new paradigm, honesty and trust are the most important. If you have that, everything is workable. The role of a manager should ...